People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Reimagine Care, Inc. | — | Healthtech | Series A | $8.7M | $7.2M | 2021 |
| NuSirt Sciences Inc. | — | Pharmaceuticals | Series A | $8.1M | $61.9M | 2015 |
Barbara Cannon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barbara Cannon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Devin Carty | 1 | 10 |
| JOSEPH C. COOK, JR. | 1 | 5 |
| Douglas French | 1 | 4 |
| Keith Figlioli | 1 | 4 |
| Chris Stenzel | 1 | 2 |
| Feby Abraham | 1 | 2 |
| Brian C. Laden | 1 | 1 |
| Dan Nardi | 1 | 1 |
| Aaron Gerber | 1 | 1 |
| Harlan Levine | 1 | 1 |
| Eric C. Satz | 1 | 1 |
| Vaughn C. Bryson | 1 | 1 |
| Michael C. Zemel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.